174 related articles for article (PubMed ID: 11760393)
1. Neutrophil activation in Behçet's disease.
Eksioglu-Demiralp E; Direskeneli H; Kibaroglu A; Yavuz S; Ergun T; Akoglu T
Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S19-24. PubMed ID: 11760393
[TBL] [Abstract][Full Text] [Related]
2. Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations.
Perazzio SF; Soeiro-Pereira PV; de Souza AW; Condino-Neto A; Andrade LE
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S85-95. PubMed ID: 26394190
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic proline-rich polypeptide is a regulator of oxidative burst in human neutrophils and monocytes.
Davtyan TK; Manukyan HA; Mkrtchyan NR; Avetisyan SA; Galoyan AA
Neuroimmunomodulation; 2005; 12(5):270-84. PubMed ID: 16166806
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet's disease.
Perazzio SF; Soeiro-Pereira PV; Dos Santos VC; de Brito MV; Salu B; Oliva MLV; Stevens AM; de Souza AWS; Ochs HD; Torgerson TR; Condino-Neto A; Andrade LEC
Arthritis Res Ther; 2017 Oct; 19(1):235. PubMed ID: 29052524
[TBL] [Abstract][Full Text] [Related]
5. The effects of nitric oxide donors and inhibitors on neutrophil functions in Behçet's disease.
Atalay G; Eksioglu-Demiralp E; Akoglu T; Direskeneli H
Clin Exp Rheumatol; 2002; 20(4 Suppl 26):S17-20. PubMed ID: 12371629
[TBL] [Abstract][Full Text] [Related]
6. Activation of neutrophils by testosterone in Behçet's disease.
Yavuz S; Ozilhan G; Elbir Y; Tolunay A; Eksioglu-Demiralp E; Direskeneli H
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S46-51. PubMed ID: 17949551
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil CD64 expression in Behçet's disease.
Ureten K; Ertenli I; Oztürk MA; Kiraz S; Onat AM; Tuncer M; Okur H; Akdogan A; Apras S; Calgüneri M
J Rheumatol; 2005 May; 32(5):849-52. PubMed ID: 15868620
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone, colchicine and iodine-lithium-alpha-dextrin act differentially on the oxidative burst and endotoxin tolerance induction in vitro in patients with Behçet's disease.
Davtyan TK; Mkrtchyan NR; Manukyan HM; Avetisyan SA
Int Immunopharmacol; 2006 Mar; 6(3):396-407. PubMed ID: 16428075
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.
Neves FS; Carrasco S; Goldenstein-Schainberg C; Gonçalves CR; de Mello SB
Clin Rheumatol; 2009 Dec; 28(12):1403-10. PubMed ID: 19701803
[TBL] [Abstract][Full Text] [Related]
10. Impaired endotoxin tolerance induction in patients with familial Mediterranean fever.
Davtyan TK; Hakopyan GS; Avetisyan SA; Mkrtchyan NR
Pathobiology; 2006; 73(1):26-39. PubMed ID: 16785765
[TBL] [Abstract][Full Text] [Related]
11. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.
Macey M; Hagi-Pavli E; Stewart J; Wallace GR; Stanford M; Shirlaw P; Fortune F
Rheumatology (Oxford); 2011 Oct; 50(10):1849-59. PubMed ID: 21719422
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric measurement of respiratory burst activity and surface expression of neutrophils for septic patient prognosis.
Bae MH; Park SH; Park CJ; Cho EJ; Lee BR; Kim YJ; Park SH; Cho YU; Jang S; Song DK; Hong SB
Cytometry B Clin Cytom; 2016 Jul; 90(4):368-75. PubMed ID: 26202936
[TBL] [Abstract][Full Text] [Related]
13. Pro-inflammatory cytokine and caspase-1 responses to pattern recognition receptor activation of neutrophils and dendritic cells in Behcet's disease.
Türe-Özdemir F; Tulunay A; Elbasi MO; Tatli I; Maurer AM; Mumcu G; Direskeneli H; Eksioglu-Demiralp E
Rheumatology (Oxford); 2013 May; 52(5):800-5. PubMed ID: 23325038
[TBL] [Abstract][Full Text] [Related]
14. Cell surface antigens expressed on polymorphonuclear cells in the peripheral blood from patients with inflammatory rheumatic diseases: two-color flow-cytometric analysis.
Mishima K; Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Tokai J Exp Clin Med; 1992 May; 17(1):41-51. PubMed ID: 1523692
[TBL] [Abstract][Full Text] [Related]
15. Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease.
Carletto A; Pacor ML; Biasi D; Caramaschi P; Zeminian S; Bellavite P; Bambara LM
J Rheumatol; 1997 Jul; 24(7):1332-6. PubMed ID: 9228133
[TBL] [Abstract][Full Text] [Related]
16. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets.
Ekşioglu-Demiralp E; Kibaroglu A; Direskeneli H; Yavuz S; Karsli F; Yurdakul S; Yazici H; Akoglu T
J Rheumatol; 1999 Apr; 26(4):826-32. PubMed ID: 10229403
[TBL] [Abstract][Full Text] [Related]
18. Dual effects of testosterone in Behcet's disease: implications for a role in disease pathogenesis.
Yavuz S; Akdeniz T; Hancer V; Bicakcigil M; Can M; Yanikkaya-Demirel G
Genes Immun; 2016 Sep; 17(6):335-41. PubMed ID: 27467286
[TBL] [Abstract][Full Text] [Related]
19. Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's disease.
Eksioglu-Demiralp E; Direskeneli H; Ergun T; Fresko I; Akoglu T
Rheumatol Int; 1999; 19(1-2):23-6. PubMed ID: 10651077
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
